The safety of skincare is an important concern for every skin type. But product safety truly becomes paramount when skin is weakened, fragile or vulnerable, for example:
- Sensitive, reactive or allergic prone skin types,
- Highly pollution-exposed skin
- Intrinsically delicate skin such as baby skin
- Skin subject to harsh medical treatments (acne medications, esthetic procedures, cancer treatments…).
We take a meticulous approach to dermocosmetics safety thanks to ingredient selection criteria, stringent testing protocols on specific populations and ongoing expert partnerships. This methodology allows us to develop products specifically suitable for the most vulnerable skin: eczema atopic-prone skin, acne-prone skin, newborns and even post-cancer treatments.
Safety from the 1st day of life
The skin of newborns is fine and delicate. We are one of the very few dermocosmetic brands to specifically formulate products for newborn babies and assess their suitability. Our two flagship products for this unique population are the gentle cleanser Lipikar Syndet AP+ and the soothing emollient Lipikar Baume AP+.
An unprecedented testing protocol in the maternity ward
For each of these two products perfectly suited to baby care, a robust clinical study was carried out under dermatological and pediatric supervision to check for any form of irritation or reaction.
The result of the 2 studies was the same: 0 adverse reactions.
With our groundbreaking testing protocols on the most fragile and vulnerable skin types – sensitive, allergic prone skin, post-cancer and even newborn skin – at La Roche-Posay, we are redefining safety expectations in dermocosmetics.
Discover LIPIKAR Baume AP+ and LIPIKAR Syndet AP+
Optimal safety even post-cancer treatments
Chemotherapy and radiotherapy can weaken skin’s defenses and cause irritation. Only the gentlest products are permitted during this key recovery period. At La Roche-Posay, we are committed to creating truly safe products able to care for cancer patients’ skin. In line with official recommendations, and along with many healthcare professionals, we are convinced that optimized dermocosmetics can contribute to an improved quality of life.
The efficacy of La Roche-Posay products such as Thermal Spring Water, Lipikar Baume AP+ and Anthelios XL SPF50+ on the cutaneous side effects and to improve patients’ quality of life has been demonstrated in 7 published studies.
To find out more about dermocosmetic skincare that can improve quality of life during cancer treatments, you can read the footnote at the end of this article*
To learn more about ESKIMO**: An expert work group for skin management in cancer, you can read the footnote at the end of this article.
* Radio- and chemotherapy can have side effects on skin: intense redness and discomfort, dryness, even fissures and pigmentation. These symptoms can make an extremely difficult time - cancer treatment and recovery - all the more distressing. To make them more bearable, published guidelines recommend a 3-step approach: a gentle cleanser, a breathable moisturizer and broad-spectrum sun protection.
For more information : click HERE
To discover how expert care products have proven their value in some of the cutaneous side effects of cancer treatments, click HERE
** Post-cancer treatment skin is the most vulnerable skin type of all, in need of intensive dermocosmetic care to help restore its comfort.
To deepen our expertise on the subject, at La Roche-Posay we have set up a targeted work group composed of expert dermatologists and oncologists specializing in the dermatological problems associated with skin cancer treatments. This work group, European SKIn Management in Oncology (ESKIMO), has analyzed and identified the various side effects of treatments and proposed recommendations for suitable skincare products and make-up.
For more information on our commitments and actions, click HERE